Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: Results from the LIPID study

AM Tonkin^*, S Eckermann, H White, D Friedlander, P Glasziou, P Magnus, A Kirby, S Mulray, M Denton, M Sallaberger, D Hunt, J Simes, LIPID Study Investigators

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review